Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs

NCT03082573 is registered in ClinicalTrials.gov with Iraj Sabahi Research Inc. as lead sponsor.

NCT NCT03082573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03082573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs
Lead sponsor
Iraj Sabahi Research Inc.
Phase
Phase 4
Overall status
Unknown status
Start date
March 3, 2017
Completion date
February 28, 2019
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis